Portage Biotech Inc.
PRTG
$5.53
-$0.50-8.29%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 73.63% | 72.02% | 73.65% | -426.03% | -443.52% |
| Total Depreciation and Amortization | -53.33% | -27.27% | -- | 1,400.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1,416.67% | -155.73% | -75.80% | 802.35% | 99.59% |
| Change in Net Operating Assets | -113.54% | 48.92% | 77.74% | -127.35% | 845.22% |
| Cash from Operations | 63.65% | 51.17% | 33.33% | -26.89% | -70.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -28.57% | -- | -- | 99.50% |
| Issuance of Common Stock | -100.00% | -99.84% | -100.00% | 572.29% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 112.12% | 100.00% | 99.90% |
| Cash from Financing | -125.64% | -101.32% | -100.19% | 591.82% | 101.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 63.08% | 40.50% | 87.77% | 198.04% | 30.71% |
